Teva Pharmaceutical Industries (TEVA) stock

Last close 42.40 USD (Nov 10, 2026), on the day −1.3 %.

• Sector: Healthcare, Drug Manufacturers - Specialty & Generic.
• Market cap: 50.1B USD.
• P/E: 99.9. Forward P/E: 13.7.
• Over 52 weeks: low 24.21 USD, high 42.97 USD, price change +74.8 %.
• Analysts' average 12-month target from Yahoo Finance: 49 USD (14 analysts). Not our estimate.

Earnings

• Jan 27, 2027: EPS not yet, estimate 0.68
• Nov 3, 2026: EPS 0.86, estimate 0.72
• Jul 29, 2026: EPS 0.02, estimate 0.11
• Apr 29, 2026: EPS 0.53, estimate 0.46
• Jan 28, 2026: EPS 0.96, estimate 0.64
• Nov 5, 2025: EPS 0.78, estimate 0.67

Which large investors hold it

• Larry Robbins – 3.4 % of the portfolio
• Stanley Druckenmiller – 0.5 % of the portfolio
• Ray Dalio – 0.2 % of the portfolio
• Cathie Wood – 0.0 % of the portfolio